Global Medical Adhesives and Sealants Market, by Product Type (Natural Medical Adhesives and Sealants (Albumin, Collagen, Fibrin, and Others), Synthetic Medical Adhesives and Sealants (Acrylic, Cyanoacrylate, Polyethylene Gycol, Silicones, and Others)), by Application (Dental, External Wounds, and Internal Wounds), by End User (Hospitals, Ambulatory Surgical Centers, Dental, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 11,982.3 Million in 2021 and is expected to exhibit a CAGR of 7.3% over the forecast period (2021-2028), as highlighted in a new report published by Coherent Market Insights.
Key players operating in the market are focusing on receiving product approvals from regulatory authorities and this is expected to drive the market growth over the forecast period.
For Instance, in November 2020, Tissium, a medtech company developing biomorphic programmable polymers for tissue reconstruction, received approval from the U.S Food and Drug Administration for its investigational Device Exemption application for its vascular sealants.
Moreover, in February 2021, Toyochem Co., Ltd, the polymer and coating arm of Japan’s Toyo Ink Group, launched a new healthcare-use in line of pressure-sensitive adhesives (PSAs) under its Oribain brand of acrylic adhesive solutions.
Global Medical Adhesives and Sealants Market – Impact of Coronavirus (Covid-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 281,808,270 cases and 5,411,759 deaths due to coronavirus disease (COVID-19) were reported till December 29, 2021, across the globe.
The COVID-19 pandemic has negatively affected several markets across the globe and is also expected to hamper the demand and supply in global medical adhesives and sealants market.
For instance, the National institute for Health Research’s (NIHR) Unit on Global Surgery, a government agency in the U.K, has put together CovidSurg, a collaborative of researchers who have created a platform of studies that explore the impact that coronavirus has had and continue to have on surgeons, surgical department and patients around the globe. The study reveals that a total of 28.4 million operations were postponed or cancelled during the 12 weeks COVID-19 surge.